Mahana Therapeutics is providing people living with gastrointestinal conditions the treatments and support they need to live their best lives.
Mahana Therapeutics is developing a brand new class of digital therapeutics treatments for patients suffering from gastrointestinal diseases such as Irritable Bowel Syndrome, Crohn’s Disease and Ulcerative Colitis.
-
Industry
-
Milestones
- Lux investment: 2018
-
Founders
- Robert Paull
LUX Partners